Advances in the treatment of late-life psychotic depression

Research output: Contribution to journalShort surveypeer-review

3 Scopus citations


The evidence base supporting the treatment of psychotic depression among older adults is scant. Although the consensus regarding the best therapeutic opinion favors electroconvulsive therapy, most patients, their families, and practitioners will exhaust medication alternatives first. Recent preliminary reports from the Study of the Pharmacotherapy of Psychotic Depression (STOP-PD) suggest a 12-week program of combined antidepressant and antipsychotic pharmacotherapy may achieve remission rates as high as 60%.

Original languageEnglish (US)
Pages (from-to)27-29
Number of pages3
JournalPrimary Psychiatry
Issue number7
StatePublished - Jul 1 2008

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Advances in the treatment of late-life psychotic depression'. Together they form a unique fingerprint.

Cite this